 Home > Active Ingredient News > Antitumor Therapy > Uterine fibroids, Relugolix treatment of uterine fibroids shows potential long-term benefits

Uterine fibroids, Relugolix treatment of uterine fibroids shows potential long-term benefits

 Last Update: 2021-04-13
 Source: Internet
 Author: User

Tags

megestrol acetate 40 mg

atorvastatin 5 mg

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Pfizer and Myovant Sciences announced that Relugolix combination therapy may have "potential benefits" for the long-term treatment of patients with uterine fibroids.

The study reached its primary endpoint, that is, 78.

The study also reached three major secondary endpoints, including the two-year sustained remission rate, the time to recurrence of severe menstrual bleeding, and the rate of amenorrhea (amenorrhoea).

Juan Camilo Arjona Ferreira, Chief Medical Officer of Myovant Sciences, said: "We are very pleased to see the positive data from the LIBERTY study, which supports the potential benefits of long-term Relugolix combination therapy.

James Rusnak, senior vice president of global product development at Pfizer and chief development officer of internal medicine and hospitals, said: “Uterine fibroids may affect the life of many women and have uncomfortable symptoms such as menstrual bleeding.

The US Food and Drug Administration Administration ( the FDA ) is currently reviewing Relugolix combination therapy for uterine fibroids application, a decision is expected to be June 1, 2021.

Manage FDA

Original source:

href="" target="_blank" rel="noopener">in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.